Efavirenz and Urinary incontinence - a phase IV clinical study of FDA data


Urinary incontinence is found among people who take Efavirenz, especially for people who are male, 50-59 old, have been taking the drug for 1 - 6 months.

The phase IV clinical study analyzes which people take Efavirenz and have Urinary incontinence. It is created by eHealthMe based on reports of 14,121 people who have side effects when taking Efavirenz from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 07, 2023

14,121 people reported to have side effects when taking Efavirenz.
Among them, 16 people (0.11%) have Urinary incontinence.

What is Efavirenz?

Efavirenz has active ingredients of efavirenz. It is often used in hiv infection. eHealthMe is studying from 14,173 Efavirenz users for its effectiveness, alternative drugs and more.

What is Urinary incontinence?

Urinary incontinence (inability to control the flow of urine and involuntary urination) is found to be associated with 2,929 drugs and 2,314 conditions by eHealthMe.

Number of Efavirenz and Urinary incontinence reports submitted per year:

Could Efavirenz cause Urinary incontinence?

Time on Efavirenz when people have Urinary incontinence *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 100 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Urinary incontinence when taking Efavirenz *:

  • female: 27.27 %
  • male: 72.73 %

Age of people who have Urinary incontinence when taking Efavirenz *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 9.09 %
  • 20-29: 0.0 %
  • 30-39: 18.18 %
  • 40-49: 18.18 %
  • 50-59: 54.55 %
  • 60+: 0.0 %

Common drugs people take besides Efavirenz *:

  1. Zidovudine: 6 people, 37.50%
  2. Combivir: 6 people, 37.50%
  3. Lamivudine: 5 people, 31.25%
  4. Abacavir: 5 people, 31.25%
  5. Fluconazole: 2 people, 12.50%
  6. Amphotericin B: 2 people, 12.50%
  7. Ritonavir: 2 people, 12.50%
  8. Bactrim: 2 people, 12.50%
  9. Didanosine: 1 person, 6.25%
  10. Abacavir Sulfate: 1 person, 6.25%

Common side effects people have besides Urinary incontinence *:

  1. Fever: 6 people, 37.50%
  2. Disturbance In Attention: 6 people, 37.50%
  3. Confusion: 6 people, 37.50%
  4. Faecal Incontinence (a lack of control over passing stool): 6 people, 37.50%
  5. Affect Lability (emotional incontinence): 5 people, 31.25%
  6. Cognitive Disorder (mental health disorders affects learning, memory, perception, and problem solving): 5 people, 31.25%
  7. Csf Protein Increased: 5 people, 31.25%
  8. Tardive Dyskinesia (a disorder that involves involuntary movements): 5 people, 31.25%
  9. Speech Impairment (Adult) (inability to speak (adult)): 5 people, 31.25%
  10. Confusional State: 5 people, 31.25%

Common conditions people have *:

  1. Tuberculosis (a bacterial infection by mycobacterium tuberculosis): 2 people, 12.50%
  2. Meningitis - Cryptococcal (inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges by cryptococcal): 1 person, 6.25%
  3. Immune Reconstitution Syndrome (immune recovery syndrome): 1 person, 6.25%
  4. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Efavirenz and have Urinary incontinence?

Check whether Urinary incontinence is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Urinary incontinence and when was it recovered:

Expand to all the drugs that have ingredients of efavirenz:

Alternative drugs to, pros and cons of Efavirenz:

Common Efavirenz side effects:

Browse all side effects of Efavirenz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Urinary incontinence treatments and more:

COVID vaccines that are related to Urinary incontinence:

Common drugs associated with Urinary incontinence:

All the drugs that are associated with Urinary incontinence:

Common conditions associated with Urinary incontinence:

All the conditions that are associated with Urinary incontinence:

How the study uses the data?

The study uses data from the FDA. It is based on efavirenz (the active ingredients of Efavirenz) and Efavirenz (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: